Avian ("Bird") Flu Stocks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avian ("Bird") Flu Stocks

NNVC 1.660

-2.4%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: - with a K	12/29/2005 11:50:35 AM
	of 428

Breaking News FDA Approves New Claims for Quidel's Flu Test Published: December 29, 2005 10:01 AM By Val Brickates Kennedy BOSTON (Dow Jones) -- Quidel Corp. said Thursday it has received U.S. regulatory clearance to promote its ten-minute flu test kit as being useful in detecting avian influenza and highly effective in diagnosing Influenza A. In a release early Thursday, the company said the Food and Drug Administration will allow it to market its QuickVue Influenza A+B test kit as being capable of detecting avian flu, also known as Influenza A subtype H5N1. Shares of Quidel (QDEL) were up 22% at $11.50 in early trade. Quidel added, however, that the kit's effectiveness in detecting avian flu has not yet been established. The product's labeling will include data on the kit's ability to detect cultured avian flu. Quidel also said the FDA will allow the test kit to be marketed with claims that it is 94% effective in detecting Influenza A, a highly prevalent flu strain. The kit can detect the presence of the virus on a nasal swab within ten minutes.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next